Phare Bio is an ambitious new social venture using novel AI and deep learning for antimicrobial development in partnership with Jim Collins' lab at MIT. Started in 2021 to address a looming crisis in antibiotic resistance, Phare is the recipient of Audacious Project prize to support big and potentially powerful solutions to the world’s most urgent challenges.
View community guidelines here: https://bit.ly/PhareBio_CommunityGuidlines
Company Details
- Employees
- 12
- Founded
- -
- Address
- A Looming Crisis In Antibiotic Resistance
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pharebio.org
Phare Bio Questions
Phare Bio's website is http://www.pharebio.org
Phare Bio's LinkedIn profile is https://www.linkedin.com/company/phare-bio
Phare Bio has
12 employees.
View email and phone details for 12
employees at Phare Bio.
Phare Bio's industry is
Biotechnology Research
Phare Bio's top competitors are
Sensible Biotechnologies,
Every Cure,
Sardine,
Advanced Research Projects Agency For Health (Arpa-H),
Gc Therapeutics,
Sympera Ai,
Variant Bio,
Ellipsis Health,
Logicflo Ai,
Didero.
Phare Bio's categories are Biotechnology Research
Phare Bio's founding year is 2020
